These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 7468770)

  • 1. Myocardial ischemia: introduction.
    Jennings RB
    Am J Pathol; 1981 Feb; 102(2):239-40. PubMed ID: 7468770
    [No Abstract]   [Full Text] [Related]  

  • 2. Symposium on Myocardial Blood Flow in Man--Methods and Significance in Myocardial Disease; Pisa, Italy; June 10-12, 1971. Introduction.
    Gregg DE
    Cardiology; 1972; 57(1):72-3. PubMed ID: 5037894
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relations between the seasonal changes in the myocardial contraction and various indices of lipid metabolism in damaged myocardium].
    Frolov VA; Efimov LV
    Biull Eksp Biol Med; 1982 Oct; 94(10):20-2. PubMed ID: 7171793
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biochemical basis for transmembrane potential changes during myocardial ischemia].
    Ma XL; Zhao RR
    Sheng Li Ke Xue Jin Zhan; 1984 Apr; 15(2):131-5. PubMed ID: 6494879
    [No Abstract]   [Full Text] [Related]  

  • 5. [Physiopathological concepts and clinico-pathological correlations on coronary disease today].
    De Soldati L
    Prensa Med Argent; 1971 Aug; 58(25):1304-11. PubMed ID: 5118442
    [No Abstract]   [Full Text] [Related]  

  • 6. Myocardial metabolism and anginal threshold in coronary disease after verapamil administration.
    Ferlinz J; Turbow ME; Aronow WS
    Clin Invest Med; 1980; 3(1-2):101-9. PubMed ID: 7471535
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fluothane, enflurane and nitrogen oxide: effects on myocardial metabolism in patients with ischemic heart disease].
    Vasil'ev AV; Sivusanghkar Sh; Margolina AA; Lepilin MG; Akchurin RS
    Anesteziol Reanimatol; 1997; (6):15-8. PubMed ID: 9511239
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism in non-ischemic myocardium during coronary artery occlusion and reperfusion.
    Buxton DB; Mody FV; Krivokapich J; Schelbert HR
    J Mol Cell Cardiol; 1993 Jun; 25(6):667-81. PubMed ID: 8411193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The physiopathological bases of the myocardium at risk].
    Santoro GM
    G Ital Cardiol; 1993 Apr; 23(4):395-401. PubMed ID: 8319868
    [No Abstract]   [Full Text] [Related]  

  • 10. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
    Schömig A; Richardt G; Kurz T
    Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Patterns and the role of changes in the sympathetic and parasympathetic regulation of the heart in local ischemia and reperfusion].
    Litvitskiĭ PF
    Patol Fiziol Eksp Ter; 1997; (2):13-8. PubMed ID: 9235531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolic compensation of human myocardial tissue in coronary heart disease].
    Chriske HW; von Smekal P; Kray D; Knabe M; Schramm G; Michel R; Hilger HH
    Verh Dtsch Ges Inn Med; 1974; 80():1066-9. PubMed ID: 4454335
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronic myocardial ischemia--hibernating myocardium: characteristics and limits].
    Heusch G; Schulz R
    Z Kardiol; 1993; 82 Suppl 5():133-41. PubMed ID: 8154154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hibernating myocardium.
    Brown TA
    Am J Crit Care; 2001 Mar; 10(2):84-91; quiz 92-3. PubMed ID: 11244676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The heart in diabetics].
    Bĕlobrádková J; Filipenský B
    Vnitr Lek; 2003 Dec; 49(12):921-6. PubMed ID: 15040156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signalling pathways in ischaemic postconditioning.
    Hausenloy DJ
    Thromb Haemost; 2009 Apr; 101(4):626-34. PubMed ID: 19350104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural changes in acute myocardial ischemia.
    Jennings RB
    Proc Inst Med Chic; 1973; 29(8):281. PubMed ID: 4698735
    [No Abstract]   [Full Text] [Related]  

  • 18. Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction.
    Skyschally A; Gres P; Hoffmann S; Haude M; Erbel R; Schulz R; Heusch G
    Circ Res; 2007 Jan; 100(1):140-6. PubMed ID: 17170366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An algorithm for construction of a mathematical model of coronary circulation disorders].
    Leshchinskiĭ LA; Rusiak IG; Ponomarev SB; Petrov AG
    Med Tekh; 1999; (4):3-6. PubMed ID: 10464752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against myocardial dysfunction induced by global ischemia-reperfusion by antisense-oligodeoxynucleotides directed at beta(1)-adrenoceptor mRNA.
    Chen H; Zhang YC; Li D; Phillips MI; Mehta P; Shi M; Mehta JL
    J Pharmacol Exp Ther; 2000 Aug; 294(2):722-7. PubMed ID: 10900253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.